Integra LifeSciences refinances debt with $1.65 B credit facility and $450 M senior notes
Integra LifeSciences completed a refinancing on Oct 19 2026 that added $1.65 billion of new senior secured credit facilities and a $450 million 9.500 % senior secured notes issue due 2033. The package includes a $600 million five‑year revolver, a $600 million five‑year term loan A and a $450 million seven‑year term loan B. Proceeds and new borrowings were used to repay and terminate the company’s 2023 credit agreement, extending debt maturities and diversifying funding sources.
Why it matters
The company says the transactions enhance liquidity and extend debt maturities, reducing refinancing risk for investors. No analyst commentary was provided in the materials.
Key facts
- 1Integra LifeSciences secured $1.65 billion in senior secured credit facilities on Oct 19 2026. tradingview.com
- 2The company completed a $450 million 9.500 % senior secured notes offering due Nov 01 2033 on Oct 19 2026. tradingview.com
- 3The new credit facilities include a $600 million five‑year revolver. tradingview.com
- 4The new credit facilities include a $600 million five‑year term loan A. tradingview.com
- 5The new credit facilities include a $450 million seven‑year term loan B. tradingview.com
- 6Proceeds and borrowings were used to repay and terminate the 2023 credit agreement with no early termination fees. tradingview.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.